Gastrointestinal Cancer
From in-home kits to colonoscopies, this article demystifies screening options for colorectal
cancer, clears up confusion, and encourages check-ups even for younger adults. Read More ›
Diane Roncone offers a heartfelt, practical guide for navigating life with anal
cancer, packed with wisdom, humor, and hard-earned tips to help others through
treatment and recovery. Read More ›
Find financial assistance programs available for gastric cancer drugs. Read More ›
Find financial assistance programs available for GIST drugs. Read More ›
By Dan Greene
At age 68, Dan Greene was told the intense pain in his abdomen was likely pancreatic cancer, until further testing determined he had stage IV stomach cancer. Joining a clinical trial gave him a second chance. Read More ›
In April 2021, the FDA approved Opdivo (nivolumab), for use with chemotherapy, as first-line treatment for patients with advanced or metastatic gastric cancer, including gastroesophageal junction cancer and esophageal adenocarcinoma. Read More ›
In May 2021, the FDA approved Keytruda (pembrolizumab), plus Herceptin and chemotherapy, for first-line treatment of locally advanced unresectable or metastatic, HER2-positive gastric or gastroesophageal junction adenocarcinoma. Keytruda is the second immunotherapy approved for gastric cancer. Read More ›
“Because gastric cancers involve the digestive system, following a healthy diet is especially important for patients with this type of cancer,” says Martha Raymond, Founding Executive Director of the GI Cancers Alliance. Read More ›